INTRODUCTION
Development of the immune system requires a sequential series of timed and coordinated events that begin early in fetal life and continue through the early postnatal period (1) . Disruption of immune development during the early neonatal period results in abnormal postnatal immune responses that are more marked and persistent than those after disruption during adult life, highlighting the importance of the neonatal period as a critical developmental window (2) . Although several host genetic and environmental factors modulate the development of the immune system during fetal and early postnatal life (3) , few are as important as the continued interaction with commensal bacteria, which is not only the most intimate environmental exposure (4, 5) but also represents a challenge to the developing immune system (6, 7) .
Commensal colonization, which begins during birth, progresses through a choreographed succession of bacterial species and evolves rapidly during the first month of life (8) . These evolving microbial signals are hypothesized to play a critical role in the functional programming of immune cells. Modern childbirth practices such as cesarean deliveries (9) and increased use of antibiotics (ABX) during early life (10) not only alter the pattern of intestinal commensal colonization in the newborn but are also associated with increased risk of sepsis and pneumonia (10) (11) (12) (13) (14) , suggesting that intestinal commensal bacteria can promote the resistance of newborn infants to pneumonia. The interaction between host and the intestinal commensal bacteria extends beyond the local enteric environment and influences immune homeostasis at peripheral sites, exemplified by intestinal complications during respiratory disease and vice versa (15, 16) . Nevertheless, the mechanistic basis of cross-talk between the intestinal commensal bacteria and innate lung defense, the socalled gut-lung axis, remains poorly defined (17) , and the developmental pathways underlying the association between commensal colonization during the early postnatal period and development of lung immunity in newborns remain unexplored.
Here, we show that interactions between the host immune system and the intestinal commensal bacteria shape the repertoires of immune cells in the newborn mouse lung and direct the postnatal ontogeny of IL-22-producing group 3 innate lymphoid cells (ILC3), a group of sentinel cells that maintain homeostasis at mucosal barrier sites. This postnatal influx of IL-22 + ILC3 promoted the resistance of neonatal mice to pneumonia. This cross-talk was mediated by mucosal dendritic cells (DCs), which captured antigen from intestinal commensal bacteria. Disruption of commensal bacteria interrupted the migratory program of ILC3, impairing their ability to traffic to the lungs and rendering the newborn mice more susceptible to pneumonia; this was reversed by exogenous IL-22 or through adoptive transfer of ILC3. Reconstitution of intestinal commensal bacteria restored the expression of CCR4 on the ILC3, restored the ability of ILC3 to migrate to the lungs, and promoted IL-22-dependent resistance to pneumonia in newborn mice.
RESULTS

Postnatal colonization by commensal bacteria promotes resistance to pneumonia in newborn mice
Previous epidemiological studies show that human infants whose mothers received frequent ABX before birth or who were delivered by cesarean section not only had altered intestinal commensal bacteria (18, 19) but also had increased risk of developing pneumonia (20, 21) . This led us to hypothesize that early-life exposure to commensal bacteria promotes resistance to pneumonia in newborns. To test this hypothesis, we exposed pregnant mouse dams to a combination of ampicillin, gentamicin, and vancomycin, three commonly used ABX in pregnant women and human newborns (Fig. 1A ) (22) , beginning 5 days before delivery. ABX were discontinued immediately after birth, and newborn mice were challenged intratracheally with Streptococcus pneumoniae serotype 19A, a leading cause of pneumonia in human newborns (23) .
This early-life ABX exposure not only reduced the total number of commensal bacteria (Fig. 1B) but also disrupted the succession of bacterial species in the intestine of newborn mice (fig. S1, A and B, and table S1A). Six hours after infection, we observed an increased bacterial load in the lungs and the bronchial lavage (BAL) fluid (fig. S1C) and increased susceptibility in newborn mice whose dams were exposed to ABX (ABX-exposed) as compared to age-matched mice whose dams were not exposed to ABX (ABX-free) (Fig. 1C) . Germfree (GF) mice, which lack commensal bacteria, similarly were more susceptible to challenge with S. pneumoniae as compared to the agematched conventionally raised (CNV) mice (Fig. 1D) . We paralleled these observations using Escherichia coli K1 or Candida albicans, other common causes of pneumonia in newborns (fig. S1, D and E) (24) . Because disruption of commensal bacteria in infancy is associated with increased susceptibility to inflammatory disorders such as allergeninduced airway hyperreactivity (25) and colitis (26) during later life, we ascertained whether disruption of postnatal commensal colonization led to durable changes in host resistance to infection. We found that increased susceptibility to pneumonia after early-life ABX exposure persisted beyond the neonatal period, until at least 4 weeks of age (Fig. 1E ). This persistence in susceptibility contrasted with the transient susceptibility to infection that occurs in ABX-exposed adult mice (27, 28) , highlighting the critical nature of commensal exposure during early life.
We reversed the commensal disruption in ABX-exposed newborns by transferring intestinal contents from a newborn mouse during the early postnatal period as done previously (Fig. 1A) (29) . Reconstitution of intestinal commensal bacteria restored resistance to pneumonia in Intestinal commensal bacteria enumerated in postnatal day 4 (P4) newborn mice exposed to ABX (ABX) or no ABX (ABX-free), quantified using real-time polymerase chain reaction (RT-PCR). (C) Survival of ABX-free or ABX-exposed P4 mice or ABX-exposed newborn mice reconstituted with intestinal commensal bacteria and infected with S. pneumoniae. (D) Survival of GF or CNV mice or age-matched GF mice reconstituted with intestinal commensal bacteria and infected with S. pneumoniae. (E) Survival of ABX-free or ABX-exposed P14 mice or ABXexposed newborn mice reconstituted with intestinal commensal bacteria and infected with S. pneumoniae. (F) Amount of IL-22 in the BAL fluid of P4 ABX-free or ABX-exposed mice or GF newborn mice or ABX-exposed or GF newborn mice reconstituted with intestinal commensal bacteria in early life. None of the newborn mice in this experimental group were inoculated with S. pneumoniae. (G) Amount of IL-22 in the BAL fluid of human newborns who were exposed to ABX or no ABX. (H) Survival of P4 ABX-free or ABXexposed newborn mice treated with IL-22 intratracheally and infected with S. pneumoniae. NS, not significant. (I) Survival of P4 ABX-free or ABX-exposed newborn mice treated with anti-IL-22 antibody (Ab) or isotype control antibody before reconstitution with intestinal commensal bacteria and infection with S. pneumoniae. Data are representative of three independent experiments. Results are shown as means ± SEM [Student's t test or analysis of variance (ANOVA) or Wilcoxon signed-rank test]. *P ≤ 0.05; **P ≤ 0.01. Numbers of individual animals (n) are indicated.
ABX-exposed and GF newborn mice (Fig. 1, C and D) . This protection against S. pneumoniae persisted beyond the neonatal period. ABXexposed mice that received intestinal contents during the early postnatal period likewise showed increased resistance to infection, at least, for as long as 4 weeks after birth compared to their littermates that did not receive intestinal bacterial reconstitution (Fig. 1, E and F) .
Whether lung-resident commensal bacteria educate the mucosal immune system, like the intestinal commensal bacteria, remains a source of controversy (30, 31) , and the effect of early-life ABX exposure to lung commensal colonization in human newborns remains unexplored. We found no difference in the composition of lung commensal bacteria in ABX-free and ABX-exposed mice ( fig. S1 , F and G, and table S1B), perhaps related to our experimental strategy of limiting ABX exposure to the pregnant dams and not the newborn mice. Lack of differences in lung-resident commensal bacteria in the ABX-exposed newborn mice as compared to ABX-free newborns suggests that intestinal commensal bacteria rather than lung commensals mediate the resistance to pneumonia, although this possibility cannot be completely excluded.
Postnatal colonization by commensal bacteria promotes interleukin-22-dependent mucosal defense in newborn mice We hypothesized that disruption of commensal colonization mediated changes in the expression of genes related to various aspects of innate lung defense. We carried out RNA sequencing analysis of lung mucosal RNA isolated from newborn mice on days 0 to 4. Unsupervised analysis revealed consistent transcriptional changes in ABX-exposed newborns as compared to ABX-free murine newborns ( fig. S1H and table S2 ). Differentially expressed genes included interleukin-22 (IL-22), a cytokine critical in lung epithelial repair ( fig. S1H) (32, 33) and host defense against pathogens (32, 34, 35) . We found decreased concentrations of IL-22 in the BAL fluid of ABX-exposed or GF newborn mice as compared to ABX-free newborn mice (Fig. 1F) . We confirmed these observations in human newborns, finding reduced concentrations of IL-22 in the BAL fluid from human newborns exposed to prolonged duration of ABX ( Fig. 1G and Table 1 ).
Reconstitution with intestinal contents from age-matched neonatal mice restored IL-22 levels in the BAL fluid of ABX-exposed or GF newborn mice (Fig. 1F) . Similarly, treatment with recombinant IL-22 intratracheally restored host resistance to pneumonia in ABX-exposed newborn mice (Fig. 1H) . To interrogate the importance of IL-22 in newborn's resistance to pneumonia, we blocked IL-22 signaling with an IL-22-neutralizing antibody (36) . Treatment of newborn mice with an anti-IL-22 antibody blocked the restoration of host resistance in ABX-exposed newborn mice after reconstitution of intestinal commensal bacteria (Fig. 1I) . IL-22 acts via a transmembrane receptor complex that consists of IL-22R1, a receptor subunit that is shared by related cytokine IL-20 (37) . We found no difference in the concentrations of IL-20 in the BAL fluid of ABX-exposed or GF newborn mice compared to ABX-free newborn mice ( fig. S1I ). Blockade of IL-20 signaling by treatment with a neutralizing antibody directed against IL-20 (38) did not block restoration of host resistance in ABX-exposed newborn mice after reconstitution of intestinal commensal bacteria ( fig. S1J) (36) . These findings demonstrate a central and nonredundant role for IL-22 in host defense against pneumonia (32, 33) and implicate IL-22 as a critical mediator by which commensal bacteria promote resistance to pneumonia in newborn mice. IL-22 bioactivity is negatively regulated by IL-22-binding protein (IL-22BP), a secreted receptor that binds to soluble IL-22 with higher affinity than IL-22R1 and functions as an antagonist (39) . We did not evaluate the role of endogenous IL-22BP in our study. Several lung-resident immune cells are known to secrete IL-22BP (40) , but the role of endogenous IL-22BP in pulmonary host defense remains unclear and may represent an additional regulatory layer in the ontogeny of lung defense in the newborn. (Fig. 2A) Fig. 2A and  fig. S2A ).
We tested these observations in human newborns.
, were a primary source of IL-22 in the lungs of human newborns ( Fig. 2B and fig. S2B ). These findings illustrate an important difference in the cellular sources of IL-22 in the lungs of newborn humans compared to adult humans, as several groups have reported that NK cells (41), T helper 17 cells (42), and gd T cells (43) are the principal sources of IL-22 in adult human lungs.
ILC3 developmentally depend on RORgt and continuously express this transcription factor (44, 45) . Therefore, to interrogate the importance of ILC3 in the resistance of newborn mice to pneumonia, we bred transgenic mice expressing Cre recombinase under the control of the RORgt promoter (46) with transgenic mice expressing inducible diphtheria toxin receptor (iDTR) (47) to generate Rorgt DTR mice. Treatment of newborn Rorgt DTR mice with diphtheria toxin (DT) decreased the number of ILC3 in the lungs ( Fig. 2C and fig. S2C ), reduced IL-22 in the BAL fluid ( fig. S2D) , and made the DT-treated Rorgt DTR newborn mice more susceptible to pneumonia (Fig. 2D ). Adoptive transfer of lung ILC3 restored host resistance to pneumonia in newborn Rorgt DTR mice treated with DT ( Fig. 2D) . Together, these data confirm that IL-22 + ILC3 are necessary and sufficient for promoting host resistance to pneumonia in newborn mice (48) .
We sought to determine whether disruption of commensal colonization altered the repertoire of IL-22-producing cells in the newborn mouse lung. We found significantly decreased (P < 0.01) numbers of IL-22 + ILC3 ( Fig. 2 , E to G), but not neutrophils, T cells, or NK cells (P > 0.05 for all) ( fig. S2E ), in the lungs of ABX-exposed or GF newborn mice as compared to ABX-free newborn mice. The decrease in the numbers of IL-22 + ILC3 persisted beyond the newborn period until at least 4 weeks of life (Fig. 2E) . We confirmed these observations in human newborns and found significantly decreased numbers of lung IL-22 + ILC3 in the BAL fluid of human newborns (P < 0.01) exposed to prolonged duration of ABX (Fig. 2H ). We then questioned whether reversing the commensal disruption would correct the immune alterations in ABX-exposed newborn mice. We found that reconstitution with commensal bacteria restored the numbers of IL-22 + ILC3 in the lungs of ABX-exposed or GF newborn mice ( We therefore hypothesized that a decrease in the absolute numbers of IL-22 + ILC3 in ABX-exposed newborn mice was due to a reduced ability of ILC3 from ABX-exposed newborns to traffic preferentially to the lungs. To test this, we used a competitive trafficking assay (49) to determine the (I) ILC3 from P4 ABX-free newborn mice were labeled with carboxyfluorescein succimidyl ester (CFSE). ILC3 from age-matched P4 ABX-exposed or ABX-exposed newborn mice reconstituted with commensal bacteria were labeled withchloromethyl-benzoyl-aminotetramethylrhodamine (CMTMR). An equal number of CFSE-or CMTMR-labeled ILC3 was adoptively transferred into ABXexposed newborn mice. Representative flow cytometry plots and absolute numbers of CFSE + or CMTMR + ILC3 in lung, spleen, or small intestine were determined 12 hours after adoptive transfer. LP, lamina propria. (J) Relative capability (homing index) of ILC3 from ABX-free or ABX-exposed or ABX-exposed newborn mice reconstituted with intestinal commensal bacteria in early life to traffic to the lungs. Data and plots are representative of three independent experiments. Results are shown as the means ± SEM (Student's t test or ANOVA or Wilcoxon signed-rank test). *P ≤ 0.05; **P ≤ 0.01. Numbers of individual animals (n) are indicated.
advantage of ILC3 isolated from ABX-free newborn mice to traffic to the lungs as compared to ILC3 from ABX-exposed newborn mice. We found that ILC3 from ABX-exposed newborn mice had decreased the ability to traffic selectively into the lungs, but not the spleen or small intestine as compared to ILC3 isolated from ABX-free newborn mice (Fig. 2, I and J). We then asked whether reversing the commensal disruption would restore the ability of ILC3 to traffic to the lungs. We similarly determined the advantage of ILC3 isolated from ABX-exposed newborn mice that had received transfer of commensal bacteria to traffic to the lungs as compared to ILC3 from ABX-exposed newborn mice that had received no such transfer. Reconstitution of commensal bacteria restored the ability of ILC3 from ABX-exposed newborns to traffic selectively to the lungs (Fig. 2, I and J). Tissue-selective ILC3 trafficking has been described for the small intestine and secondary lymphoid tissues (50, 51) . Our data unveil a role for intestinal commensal bacteria in selective trafficking of ILC3 into the lungs. Commensal bacteria modulate expression of CCR4 on ILC3 and direct their postnatal trafficking to the lungs Chemokines control the trafficking and positioning of immune cells and are critical for development and recruitment of immune cells in disease (52) . We first identified the repertoire of chemokine receptors on IL-22 + ILC3 from the lungs or small intestine of newborn mice. We found that CCR4 was highly expressed by most of IL-22 + ILC3 from the newborn murine lung but not from the newborn murine small intestine ( fig. S3A) . We found no difference in the expression of CCR6, CCR7, CCR9, or CCL20 nor CXCR3 or CXCR5 on IL-22 + ILC3 from the newborn lung or small intestine ( fig. S3A ). Tissue-selective ILC3 trafficking has been described for the intestine (50, 51) but not for the lungs. Like the intestine, the lung has a large mucosal surface, which is in continuous contact with the environment and therefore can potentially benefit from lung-selective ILC3 trafficking.
We hypothesized that exposure to commensal bacteria during early life may modulate the expression of lung-specific homing receptors on IL-22 + ILC3 and thus increase their ability to traffic to the lungs. We examined the numbers and frequencies of CCR4 expressing IL-22 + ILC3 in the lungs of ABX-exposed or ABX-free newborn mice. We found that most of IL-22 + ILC3 from the lungs of ABX-free newborn mice were CCR4
high as compared to the lung ILC3 from ABX-exposed mice or GF mice, which were CCR4 low (Fig. 3A) . We found no difference in expression of CCR6, CCR7, CCR9, CCL20, CXCR3, or CXCR5 on IL-22 + ILC3 from the lungs of ABX-free or ABX-exposed mice (Fig.  3A) . CCR4 is critical for homeostatic trafficking of T lymphocytes (53) and regulatory T cells (54) into the lungs. CCL17, one of the ligands for CCR4, is expressed by the lung epithelium (55) . We therefore hypothesized that commensal bacteria use a similar mechanism to direct trafficking of ILC3 into the newborn lungs. To test this hypothesis, we determined the capability of ILC3 isolated from newborn mice lacking CCR4 (Ccr4 −/− ) to traffic to the lungs as compared to ILC3 from age-matched wild-type littermates. We found that ILC3 from newborn Ccr4 −/− mice had decreased ability to traffic into the lungs as compared to ILC3 isolated from wild-type littermates (Fig. 3B) . Furthermore, the newborn Ccr4 −/− mice were more susceptible to pneumonia compared to wild-type littermates (Fig. 3C) . We then asked whether an adoptive transfer of wild-type ILC3, which express CCR4 and therefore traffic into the lungs, could improve host resistance in newborn Ccr4 −/− mice. We found that adoptive transfer of ILC3 from wild-type newborn mice to age-matched Ccr4 −/− mice restored host resistance to pneumonia (Fig. 3C) . These data illuminate a role for CCR4 in trafficking of ILC3 into the lungs and promoting newborn's resistance to pneumonia. Nevertheless, the origin of ILC3 that traffic to the lungs is unknown. ILC3 are concentrated within the small intestine (51) , and the spatial proximity of ILC3 with commensal bacteria in the small intestine supports the notion that ILC3 in the intestinal mucosa may be directed by the commensal bacteria to traffic to the lung.
CD103 +
CD11b
+ DCs capture antigen from commensal bacteria and induce expression of CCR4 on ILC3 We sought to identify the mechanisms by which intestinal commensal bacteria induce the expression of CCR4 on ILC3. Murine ILC3 do not express pattern recognition receptors and therefore are unlikely to directly sense the commensal bacteria (56) . Mononuclear phagocytes, such as DCs and macrophages, not only detect a range of microbial signals (57) but can also cross-talk with ILC3 in the intestine (58 fig. S3D ), reduced numbers of ILC3 in the lungs, and increased susceptibility to pneumonia of DT-treated Zbtb46 DTR newborn mice (Fig. 3, E and F + DC-depleted newborn mice) restored the number of lung ILC3 and improved the resistance of newborn mice to pneumonia (Fig. 3, E and F) .
There is increasing evidence that intestinal DCs act as conductors of ILC traffic to the intestine and secondary lymphoid tissue (50 
+ DCs isolated from the small intestine of ABX-free or ABX-exposed newborn mice with ILC3 isolated from the lungs of ABX-free or ABX-exposed newborn mice. CD103 +
+ DCs isolated from the small intestine of ABX-free newborn mice were more efficient than CD103 +
+ DCs isolated from the small intestine of ABX-exposed newborn mice at inducing CCR4 expression on IL-22 + ILC3 (Fig. 3, G and H) and restoring the ability of lung ILC3 from ABX-exposed animals to migrate in response to the CCR4 ligand CCL17 in vitro (Fig. 3I) . We found no change in the expression of CCR6, CCR7, CCR9, CCL20, CXCR3, or CXCR5 (Fig.  3G) . Conversely, coculture of CD11b
− DCs isolated from the small intestine of either ABX-free or ABX-exposed newborn mice did not change the CCR4 expression on IL-22 + ILC3 ( fig. S3E) 
+ DCs abrogated the increase in the ILC3 number in ABX-exposed newborn Zbtb46 DTR mice after reconstitution with intestinal commensal bacteria (Fig. 3J) 
+ DCs, are likely to play a major role in selective trafficking of ILC3 to the lung. Because previous reports (66, 67) implicated IL-1b in cross-talk between intestinal mononuclear phagocytes and small intestine ILC3, we measured IL-1b in the supernatant from cocultures of DCs and ILC3. We found no difference in the IL-1b levels in coculture supernatants of CD103 + CD11b + DCs isolated from the small intestine of ABX-free or ABX-exposed newborn mice and cocultured with ILC3 ( fig. S3F ), suggesting that IL-1b may not be involved in cross-talk between DCs and ILC3.
DISCUSSION
Distinct immune responses specifically adapted for fetal and early postnatal life render newborns more vulnerable to infection (1). Lack of understanding of immune development in early life contributes to our inability to reduce neonatal morbidity due to pneumonia, which unfortunately kills more newborns than any other cause. Although a series of coordinated events control the development of a newborn's immune system (3), few are as important as the interaction with successive waves of commensal bacteria, which colonize the newborn's intestine immediately after birth (4, 5) . Disruption of commensal colonization in the critical window of the early postnatal period has enduring consequences for the developing immune system, exemplified by increased risk of inflammatory disorders such as asthma and increased risk of respiratory infections beyond infancy in those infants exposed to prolonged ABX treatment or delivered by cesarean section (10) (11) (12) (13) (14) . To develop therapeutic interventions to decrease morbidity in the newborn period and beyond, we need to better understand the role of commensal colonization in the development of the newborn immune system.
Previous studies investigating commensal bacteria-driven immune maturation have prioritized the use of GF mice (68) . It is now accepted that the immune system, although not immature in early life, differs fundamentally from immune responses in adults (1) . The newborn's intestine is colonized by successive waves of diverse commensal bacteria, and the newborn's intestinal microbiota is fundamentally distinct from that of adult mice (29) . Thus, commensal reconstitution studies in adult GF mice do not fully capture the complex interaction between the developing host and evolving microbiota. We exposed pregnant mouse dams to a combination of ABX, used commonly to treat mothers and infants. This not only disrupted the sequential colonization of the newborn's intestine by different commensal bacteria but also made the newborn mice more susceptible to pneumonia, replicating the key observations from epidemiological studies (10) (11) (12) (13) (14) . The susceptibility to pneumonia in ABX-exposed newborn mice persisted beyond the newborn period, in contrast to previous reports (27, 28) , showing that ABX exposure in adult mice induced only transient susceptibility to infection. Reversing the commensal disruption restored the resistance to pneumonia in the ABX-exposed newborn mice, and this protection persisted beyond the newborn period. These results coupled with other recent reports (25, 26) highlight the importance of therapeutic interventions addressing commensal dysbiosis in early life that have lasting consequences.
T cells (32) and NK cells (41) are primary mediators of innate mucosal defense against respiratory pathogens in adults. We found that, during birth, the mouse lung is populated by a few IL- (69) . ILC3 were dispensable for protection against influenza A pneumonia (70). Reports ascribing an important role for ILC3 in lung immune homeostasis have used adult mice deficient in recombination-activating gene 2 (Rag2) or IL-2 receptor g (Il2rg) (48, 71) , which are profoundly immunodeficient, or treated with anti-CD90.2 antibodies (35), resulting in nonspecific depletion of several immune cell types, thus confounding interpretation of results from these animals. We therefore generated Rorgt iDTR mice, a genetic tool to selectively deplete ILC3. First, by showing that ILC3 depletion in early life rendered the newborn mice more susceptible to pneumonia, we were able to demonstrate that IL-22 + ILC3 were necessary to promote the resistance of newborn mice to pneumonia. Second, by restoring the resistance to pneumonia in ILC3-depleted newborn mice after adoptive transfer of ILC3, we established that ILC3 were sufficient to promote newborn's resistance to pneumonia. One limitation of Rorgt iDTR mice is potential depletion of the RORgt + T cells after DT treatment. However, both human newborns (72) and murine newborns (73) are relatively lymphopenic compared to adults. Absolute numbers of IL-22 + T cells were low in the newborn mice (Fig. 2B) , suggesting that depletion of RORgt + T cells in our Rorgt iDTR mice may have had only a marginal effect on the newborn's resistance to infections.
Having shown that ILC3 played a critical role in promoting the resistance of newborn mice to pneumonia, we investigated the role of commensal bacteria in the postnatal development of lung IL-22 + ILC3. Several groups have demonstrated that colonization with commensal bacteria increased the number of IL-22 + ILC3 in the small intestine of adult GF mice (74, 75) . Similarly, an increase in the number of IL-22 + ILC3 in the postnatal period has been described for the small intestine (76, 77) but not for the lung, raising the possibility that this phenomenon is restricted to the newborn's intestine. Our data challenge this assump- , which needs to be clarified in the context of recent reports that ILC homeostasis at peripheral sites is dependent primarily on self-renewal (78) .
Small intestine-specific trafficking of ILC3 depends on the expression of chemokine receptors CCR9 and a 4 b 7 by ILC3 (50) . In contrast, we found that lung-specific trafficking of IL-22 + ILC3 was mediated by CCR4, a homing receptor also used by other immune cells (79) for homeostatic trafficking into the lung. CCR4 is activated by chemokine CCL17 or CCL20. CCL17 is expressed by the lung epithelium (55) . There is evidence that intestinal DCs act as conductors of ILC3 traffic to the small intestine and secondary lymphoid tissue, but not to the lungs (50, 51) . We therefore evaluated the role of intestinal DCs in instructing IL- + DCs, which is a potential limitation of our study. In conclusion, our data demonstrate the importance of commensal exposure in a defined developmental window during the newborn period in the development of pulmonary mucosal immunity in mice. We illuminate a critical role for intestinal commensal bacteria in lung-selective trafficking of IL-22 , promoting the newborn's resistance to pneumonia. These data also potentially explain the association between cesarean delivery or widespread use of ABX and an increased risk of infections in newborn infants. Finally, similar mechanisms could influence the development of other pulmonary inflammatory disorders such as asthma, which is also associated with cesarean delivery and ABX use during early life (81) , and lead to new therapeutic agents to mitigate the risk associated with early-life ABX exposure in children.
MATERIALS AND METHODS
Study design
The Institutional Animal Care and Use Committee (IACUC) at Cincinnati Children's Hospital Medical Center (CCHMC) approved all the animal studies (IACUC2014-0055), which were carried out in accordance with the National Institutes of Health's Guide for the Care and Use of Laboratory Animals. We bred Rorgt-Cre mice with Rosa26-iDTR mice to generate Rorgt iDTR mice. We maintained C57/BL6, Rosa26-iDTR, Rorgt-Cre, or Zbtb46 DTR mice at the CCHMC animal facility. We maintained the GF C57/BL6 neonatal mice in plastic isolator cages with autoclaved feed and water at the CCHMC Germ-Free Core facility. After birth, neonatal mice from multiple litters were pooled and redistributed to control for the founder effect and to minimize in-cage variations. We used neonatal C57/BL6, Zbtb46 DTR , Rorgt DTR , or GF C57/BL6 mice between P1 and P14 and appropriate age-, sex-, and genetic strain-matched controls to account for any variations in data. We treated pregnant female mice (C57/BL6 or Zbtb46 DTR ) with sterile drinking water mixed with three different ABX (ampicillin, gentamicin, and vancomycin; all at 1 mg ml −1 ) starting from embryonic day 15 until the delivery of neonatal mice. We determined group sizes necessary for adequate statistical power analysis using preliminary data sets. There was no randomization designed in the experiments, and we did not exclude any samples. The investigators were not blinded to group allocation during collection and analysis of the data.
Murine neonatal pneumonia studies
We grew S. pneumoniae serotype 19A (American Type Culture Collection 700674) or E. coli serotype K1 (82) or C. albicans (37°C, 200 rpm) in tryptic soy broth to log-phase growth. To mimic S. pneumoniae or E. coli or C. albicans pneumonia, we inoculated neonatal mice (P4 or P14) with either S. pneumoniae serotype 19A [10 5 colony-forming units (CFUs) g ), respectively, via intratracheal route. The animals were examined every 6 hours for signs of distress and were euthanized 72 hours later or earlier if moribund. To assess bacterial burden, we homogenized the lung in sterile phosphate-buffered saline (PBS). We plated serial dilutions of lung homogenates or BAL fluid in tryptone soya broth agar plates and incubated (37°C, overnight) to count the number of CFUs.
We pooled intestinal contents from no ABX-exposed P2 newborn mice. We transferred intestinal contents (200 mg in 50 ml of PBS) or vehicle (50 ml of PBS) to ABX-exposed neonatal P2 mice by a single oral gavage via fine polyethylene tubing as described previously (29) .
Isolation and characterization of IL-22
+ cells in the murine neonatal lung We pooled and cut the fresh lungs from three to four newborn mice and incubated (37°C, 30 min) the cut tissues with shaking (150 rpm) in digestion buffer [RPMI 1640 with 10% fetal bovine serum (FBS), 15 mM Hepes, 1% penicillin/streptomycin (w/v), and collagenase VIII (300 U ml −1 )] and pressed through a 100-mm nylon strainer to obtain single-cell suspension. The pooled preparation constituted a single data point in our analysis. We then incubated (37°C, 5 hours, 5% CO 2 ) the cells (1 × 10 7 ) in culture medium containing RPMI 1640 with 10% fetal calf serum (FCS), 1× nonessential amino acids, 10 mM Hepes, 2 mM L-glutamine (all from Invitrogen), and 1% penicillin/ streptomycin with GolgiStop (1:1000; 554724, BD Biosciences), phorbol 12-myristate 13-acetate (PMA; 10 ng/ml), and calcium ionophore A23187 (500 ng/ml) (both from Sigma-Aldrich). We washed and incubated (4°C, 10 min) the cells (1 × 
Isolation and characterization of antigen presenting cells in the murine newborn intestine
We pooled and cut the freshly resected terminal ilea from three to four neonatal mice into 2-to 5-mm pieces and incubated (37°C, 15 min) them with extraction buffer (Hanks' balanced salt solution, 15 mM Hepes, and 1 mM EDTA) to remove the epithelial cells. We then incubated (37°C, 30 min) the cut tissues with shaking (150 rpm) in digestion buffer [RPMI 1640 with 10% FBS, 15 mM Hepes, 1% penicillin/ streptomycin (w/v), and collagenase VIII (300 U ml We collected the data with LSR II (BD Biosciences) and analyzed the data with FlowJo (Tree Star). (71) . This resulting cell population was >97% enriched for ILC3 (71) . We harvested 1 × 10 7 intestinal CD103 + CD11b + DCs from the pooled small intestine specimens by positive and negative selection as done previously (83) . We adoptively transferred Lin 
In vivo ILC3 migration assay
We first isolated lung Lin 
CCR6
+ cells (>97% ILC3) by positive and negative selection as done previously (71) . We then incubated (37°C, 20 min) ILC3 (1 × 10 7 ) from P3 GF or ABX-exposed newborns with CFSE (5 mM). We incubated ILC3 from control (ABX-free) neonatal mice with CMTMR (10 mM). We quenched with an equal volume of 10% FBS, diluted 10× with PBS, and resuspended the cells in RPMI 1640, supplemented with 2% FBS and 2 mM glutamine. We co-injected 10 6 cells of each population into ABX-exposed neonatal mice via intraperitoneal route. We euthanized host mice 24 hours later and determined the numbers of injected ILC3 migrating into the lungs, spleen, and small intestine by flow cytometry as done previously (50 (10 5 cells each) in the following combinations (ILC3 from ABX mice + DC from no-ABX mice; ILC3 from ABX mice + DC from ABX mice, ILC3 from ABX-free mice + DC from ABX-free mice, or ILC3 from ABX-free mice + DC from ABX mice; ILC3 from ABX or ABX-free mice alone, or DC from ABX and ABX-free mice alone) in round-bottom plates in RPMI 1640 supplemented with 2% FBS, 2 mM glutamine, and 50 mM b-mercaptoethanol. We harvested the supernatants, and the remaining cells were incubated with GolgiPlug and subsequently analyzed by flow cytometry. For chemotaxis assay, we loaded ILC3 (10 6 cells in 100 ml of RPMI 1640 supplemented with 2% FBS) into Transwell inserts with pore size of 5 mm (Corning Transwell) and placed in wells containing ±20 nM CCL17 in RPMI 1640, supplemented with 2% FBS, 2 mM glutamine, and 50 mM b-mercaptoethanol. We incubated (2 hours, 37°C) the plates and then analyzed the migrated and input cells by flow cytometry. We expressed results as percentages of ILC3 in migrated wells as compared to input wells as described previously (50) .
Sample collection and analysis of commensal bacteria in the lungs and small intestine of newborn mice Given the technical challenges in collecting adequate biospecimens for 16-s sequencing from newborn mice, we opted to pool biospecimens from 8 to 10 newborn mice from three separate litters per treatment group. An unexpected benefit of this approach is the control of variations in the commensal bacteria attributed to founder and cage effect (84) . We collected the entire left lobe of the lung using one heat-treated sterile scissors per animal as described previously by other groups (85) . We then cut open the terminal ileum using sterile scissors and removed intestinal contents using sterile plastic loops as done previously (29) . We snap-froze (−80°C) the specimens for subsequent analysis (−80°C). We extracted the bacterial DNA from the whole lung or the intestinal contents using QIAamp DNA Stool Mini Kit (Qiagen) using a previously described protocol (85) and quantified 16S ribosomal (r) DNA by RT-PCR using degenerate primers as described previously (86) . To analyze the commensal bacteria, we amplified the variable 2 region of microbial 16S rRNA by high-fidelity PCR with bar-coded 8F and 338R universal primers with A and B sequencing adaptors, respectively, and bifido primers (Roche) and sequenced them with Genome Sequencer FLX Titanium system (Roche) at the University of North Carolina Microbiome Core Facility (Chapel Hill, NC). The reagents used for DNA extraction, PCR, and sequencing reaction are a common source of contamination in microbiome sequencing studies (87) . To control for variation in the reagents, we processed all the samples using a common batch of DNA extraction reagents and PCR reagents. We included appropriate controls including a negative control (no template) and positive community control (intestinal contents from age-matched mice) from each batch of harvested tissues when performing 16S rRNA PCR or 16S rRNA sequencing. We decoded and processed the sequences using the QIIME software package (version 1.7) and custom R package code (88) . Analysis of the sequences from negative control indicated the presence of several bacterial species, suggesting potential contamination from the DNA extraction or sequencing reagents. The dominant bacterial species in the negative control were Rhodocyclaceae (17%), Rhizobiales (15%), Agrobacterium (14%), Micrococcus (10%), Hydrogenophilus (9%), Neisseria (5%), Lysinibacillus (4%), Micrococcus (4%), and Tenericutes (4%). The relative abundance of these contaminants in experimental samples was less than 3% (table S1) and thus unlikely to alter the conclusions. We used phylogenetic diversity to compute and visualize a diversity and unweighted and weighted UniFrac for b diversity. We tested the observed differences in UniFrac distances between ABX-treated groups and across different ages for significance using a t test, and we corrected the reported P values for multiple comparisons using a Monte Carlo permutation procedure with 10,000 iterations. We deposited all data sets in a publicly available database (figshare), which can be accessed at https://figshare.com/s/52f4aa2f8035fd505cf1.
Transcriptomics analysis
We sequenced high-quality RNA from the whole lung at CCHMC Sequencing Core Facility with an Illumina HiSeq 2500. We performed data alignment with TopHat, followed by gene quantification [fragments per kilobase million (FPKM)] using Cufflinks. We carried out differential expression analysis with both FPKM and read count-based methods. We performed pathway and network analyses with AltAnalyze as described previously (89) . We deposited all data sets in a publicly available database (figshare), which can be accessed at https://figshare. com/s/52f4aa2f8035fd505cf1.
Human newborn studies
The Institutional Review Board (IRB) at CCHMC approved all the human studies. The biological samples were initially collected from infants who underwent clinical evaluation of either upper airway obstruction or tracheobronchomalacia, common anomalies of the airways in infants, after obtaining informed consent from the parents (IRB approval #2013-3309). The BAL fluid samples were centrifuged (4°C, 10 min, 400g). The resultant supernatant was frozen (−80°C), and the cells were cryopreserved (−150°C) in 90% FBS and 10% dimethyl sulfoxide. We used the frozen supernatant and cryopreserved cells in our analysis (IRB approval #2015-7983). Because pneumonia (48) and asthma (71) are associated with ILC3 activation in the lungs, we excluded infants with a history of pneumonia (defined as worsening of respiratory status, increase or change in the quality of respiratory secretions, and temperature instability with radiographic changes) or wheezing. We then selected infants who received ABX (ABX-exposed group) or no ABX (no-ABX group) and matched the respective treatment groups for gestational age, age at the time of procedure, and history of mechanical ventilation. Characteristics of the subjects are provided in Table 1 . After thawing, we incubated (37°C, 5 hours, 5% CO 2 ) the cells (0.5 × 10 6 ) in culture medium containing RPMI 1640 with 10% FCS, 1× nonessential amino acids, 10 mM Hepes, 2 mM L-glutamine (all from Invitrogen), and 1% penicillin/ streptomycin with GolgiStop (1:1000; 554724, BD Biosciences), PMA (10 ng/ml), and calcium ionophore A23187 (500 ng/ml). We immunophenotyped the cells in BAL fluid as described previously (90) . We stained cells with anti-human CD3 antibody (SP34-2), anti-human CD8 antibody (B9.11), anti-human CD14 antibody (RMO52), anti-human CD19 antibody (J3-119), anti-human CD45 antibody (J.33), anti-human CD56 antibody (NK901), anti-human CD69 antibody (TP1.55.3), and anti-human NKp46 antibody (9E2) (all diluted 1:1000; BioLegend). For intracellular staining, we washed and fixed (4°C, 60 min) the surfacestained cells in 1× Cytofix/Cytoperm buffer (BD Biosciences) and permeabilized them (4°C, overnight) using 1× Permeabilization buffer (BD Biosciences) according to the manufacturer's instructions. We stained the cells intracellularly with anti-human RORgt antibody (AFKJS-9), anti-human T-bet antibody (4B10), and anti-human IL-22 antibody (BG/IL-22) (all diluted 1:50; BioLegend) and then washed (twice) and resuspended them in flow cytometry buffer. We collected the data with LSR II (BD Biosciences) and analyzed the data with FlowJo (Tree Star).
Enzyme-linked immunosorbent assay
We measured IL-22 or IL-20 in the murine (69) or human BAL fluid (91) using commercially available kits (eBioscience) as described previously. We measured IL-1b in the cell culture supernatant using commercially available kits (eBioscience) according to the manufacturer's instructions.
Statistical analyses
Each data point represents a pool of three to four newborn mice that were pooled before the isolation of leukocytes from the indicated tissue. All data met the assumptions of the statistical tests used. We compared differences between groups by either unpaired two-tailed Student's t test, ANOVA, or Wilcoxon signed-rank test. We used the Kaplan-Meier log-rank test to compare survival between groups (all in GraphPad Prism 6.0). P values are indicated as *P ≤ 0.05 or **P ≤ 0.01.
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